These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis. Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546 [No Abstract] [Full Text] [Related]
3. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Kawanami S; Tsuji R; Oda K Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620 [TBL] [Abstract][Full Text] [Related]
4. Protection of immunoreactivity of dry immobilized proteins on microtitration plates in ELISA: application for detection of autoantibodies in myasthenia gravis. Nguyen VK; Leclerc N; Wolff CM; Kennel P; Fonteneau P; Deyes R; Warter JM; Poindron P J Biotechnol; 1999 Jun; 72(1-2):115-25. PubMed ID: 10406102 [TBL] [Abstract][Full Text] [Related]
5. Mesangial proliferative glomerulonephritis with deposits of anti-nicotinic acetylcholine receptor antibody in a patient with myasthenia gravis. Mitsui T; Okada K; Kuhara T; Hashizume T; Okazaki S; Kawajiri M; Matsumoto T J Clin Neurosci; 2001 Sep; 8(5):454-6. PubMed ID: 11535018 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis. Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435 [TBL] [Abstract][Full Text] [Related]
7. A solid-phase enzyme immunoassay for anti-acetylcholine receptor antibody in myasthenia gravis patients. Kobayashi N; Sugita H; Terada E; Ghoda A; Okudaira H; Ogita T; Miyamoto T J Immunol Methods; 1984 Oct; 73(2):267-72. PubMed ID: 6386990 [TBL] [Abstract][Full Text] [Related]
8. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)]. de Crousaz G Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693 [No Abstract] [Full Text] [Related]
9. An enzyme-linked immunosorbent assay for antibodies against saline-soluble muscle components in myasthenia gravis. Akazawa S; Furukawa S; Kamo I; Furukawa Y; Satoyoshi E; Hayashi K J Immunol Methods; 1986 Nov; 94(1-2):161-7. PubMed ID: 3782808 [TBL] [Abstract][Full Text] [Related]
10. Acetylcholine receptor antibodies in myasthenia gravis: use of a qualitative assay for diagnostic purposes. Oger J; Kaufman R; Berry K Can J Neurol Sci; 1987 Aug; 14(3):297-302. PubMed ID: 3664371 [TBL] [Abstract][Full Text] [Related]
11. Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies. Lagoumintzis G; Zisimopoulou P; Trakas N; Grapsa E; Poulas K; Tzartos SJ J Neuroimmunol; 2014 Feb; 267(1-2):1-6. PubMed ID: 24412396 [TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of the canine nicotinic acetylcholine receptor alpha-subunit gene and development of the ELISA method to diagnose myasthenia gravis. Yoshioka T; Uzuka Y; Tanabe S; Sarashina T; Ishiguro N Vet Immunol Immunopathol; 1999 Dec; 72(3-4):315-24. PubMed ID: 10628675 [TBL] [Abstract][Full Text] [Related]